The Pancreatic Cancer Drugs Market is segmented by Drug Type (Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation), Afinitor (Everolimus), Erlotinib Hydrochloride, Everolimus, 5-FU (Fluorouracil Injection), Fluorouracil Injection, Gemcitabine Hydrochloride, Other), Cancer Type (Endocrine Pancreatic Cancer, Exocrine Pancreatic Cancer), End-User (Hospitals, Clinics), and Region (North America, Europe, Asia-Pacific, and the Rest of the World).

Market Dynamics

The growth of the pancreatic cancer drugs market is primarily driven by:

  • Rising incidences of pancreatic cancer due to obesity, high consumption of alcohol, and smoking.
  • Expanding the geriatric population is likely to drive the market growth further. It can also occur as a result of a family history of pancreatitis mutation.
  • Increasing investment in research and development activities to develop advanced diagnostic solutions is likely to create lucrative opportunities for the players operating in the global pancreatic cancer drugs market in the coming years. However, the high treatment cost is likely to affect the growth of the pancreatic cancer diagnostic market.

Key Players

Key players operating in the pancreatic cancer drugs market are-

  • Eli Lilly and Company (US)
  • Celgene Corporation (US)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Novartis International AG (Switzerland)
  • Clovis Oncology (US)
  • Amgen Inc. (US)
  • The Merck Group (Germany)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Pfizer Inc. (US)
  • PharmaCyte Biotech, Inc. (US).

Regional Analysis

The North American market accounted for the largest market share in 2020 and is projected to grow at a robust CAGR during the review period. This can be attributed to the growing emphasis on the adoption of advanced diagnostic solutions in the healthcare industry coupled with the presence of key market players such as Eli Lilly and Company (US) and Celgene Corporation (US). The market growth in Asia-Pacific is expected to be driven by an increasing number of people suffering from pancreatic cancer.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.